A new topical treatment from PCA Advanced Skin Care Systems visibly restores lip fullness and reduces furrows non-invasively. Peptide Lip Therapy gives lips a lush appearance with a novel pairing of the latest in peptide technology and BMX COMPLEXä, a moisture boosting blend derived from barley and tomato extracts.

Clinical studies of BMX COMPLEXä showed visible improvement in attracting and retaining moisture after two weeks with a 40% increase in hydration and a 30% reduction in flaking and moisture loss. The natural peptide, GlyHisLys, also delivered dramatic tissue restructuring and moisturizing properties with an average of 40% increase in lip volume and a 30% decrease in lip lines after 29 days of use.

Peptide Lip Therapy’s advanced delivery system uses a lipid complex to maximize penetration into the stratum corneum and antioxidants to strengthen the lip’s natural defenses against dryness, flaking and damage from environmental exposure.

PCA Advanced Skin Care Systems is an industry leader in the development of chemical peels and advanced topicals to aid in correcting acne, eczema, hyperpigmentation, psoriasis, rosacea and premature aging due to sun damage. Company founder, Margaret Ancira, revolutionized the skin care industry in 1990 with the first non-prescription, science-based skin care products for physicians. PCA Professional™ Products, PCA® MEN, and PCA SKIN ® Clinical Care Products are used by clinical practices in 60 countries.

PCA Advanced Skin Care Systems
877.PCA.SKIN
www.pcaskin.com

Citing physician demand for a medical Internet domain, MaxMD, a Jersey City, NJ, based service provider, has launched the .md domain. The new domain means doctors, hospitals, and universities can now use .md, rather than .com or .edu to show their affiliation with the medical community.

The domain is available in the United States and more than 90 other countries. Basic registration includes the .md domain, a Web card to activate the domain, and a secure email account for $150 per year.

“The domain was officially launched last December, but MaxMD has been registering members for about two years, mainly through word of mouth,” says Seanne Murray, Senior Vice President of MaxMD. The domain has approximately 10,000 members, including individual physicians, practice groups, medical institutions, and universities. The company expects membership to climb to 50,000 by the end of the year.

MaxMD (www.max.md) acquired the exclusive rights to market and distribute the .md domain in 2003. The company then conducted research to determine what physicians and others in the health care community want from the Internet. “Physicians want to have a place where they can be identified as medical experts online, much like educators identify themselves with .edu and nonprofits identify themselves with .org,” says Murray.

MaxMD
877.629.6363
www.max.md

As they enter their sixties, baby boomers expect to be granted three wishes: to enjoy good health, remain active, and look fit. The boomer generation and their younger counterparts understand that taking good care of their skin will help them continue to look as good as they feel. As their trusted gynecologist/obstetrician, your patients look to you to bring them proven technology to safeguard good health, including glowing skin.

A more natural perspective on healthy aging has emerged as a priority for people interested in maintaining vitality. Meeting this need, Salt-A-Peel MacroDermabrasion Therapy, the original sodium chloride-based skin rejuvenation system from IntegreMed, offers a natural approach to skin renewal. The next-generation, environmentally friendly system will be on exhibit at the 54th Annual Clinical Meeting of The American College of Obstetricians and Gynecologists, May 6-10, in Washington, D.C ., providing an opportunity for attendees to learn how Salt-A-Peel MacroDermabrasion Therapy can help expand their patient base and boost the bottom line.

Salt-A-Peel MacroDermabrasion Therapy’s unique, proprietary crystal delivery system offers a more effective treatment than conventional microdermabrasion methods. This therapy is an easily tolerated, non-invasive process which uses water-soluble, non-toxic salt—not an artificially created chemical substance with potential health hazards—to safely and gently abrade the skin. Patients experience immediate benefits and enjoy longer-lasting results in fewer treatments.

The MicroPro S10 MacroDermabrasion System with Smart Sensing Technology™ activates the treatment when the handpiece comes into contact with tissue and turns off when the handpiece is removed. Using adjustable positive pressure, not a vacuum, the topmost layers of skin (stratum corneum) are efficiently removed without excessive flushing/redness (erythema), edema or trauma to the area. Twice as much tissue is removed per pass than with alternative treatments. The ability to cover larger areas of skin with fewer passes minimizes discomfort and expedites treatment time.

IntegreMed
877.733.7627
www.integremed.net

GPT Glendale, Inc., the world leader in laser eyewear, has introduced Glendale XC, the first laser safety spectacle to feature the combination of incomparable wrap-around protection, style, comfort, and a prescription insert. Glendale’s patented Multi-Material Technology (MMT) cushions every point of contact with the worker’s face for unparalleled comfort and impact resistance. Renowned for innovation, Glendale’s newest offering provides the extra coverage, style, and protection which laser workers require.

The patented, dual 9-base wrap-around polymer lens extends protection to more than 180 degrees of coverage, providing uninterrupted peripheral vision and reducing exposure to light from lasers more than any other spectacle in the industry. Every pair of the Glendale XC comes with a detachable prescription insert frame that fits from +3.0 to - 3.0 diopters. Prescriptions can be filled by any local optician. Glendale XC lenses also feature anti-fog coating for humid or extreme conditions.

MMT, Glendale’s state-of-the-art molding technology, combines multiple materials to produce a featherweight frame. The soft brow guard and flexible “fingers” cushion every point of contact with the face, brow, nose and ear. Glendale XC eyewear also features adjustable temple length and lens inclination, making it the most adjustable and comfortable laser eyewear product on the market.

Available for use with today’s most common lasers, all models of Glendale XC meet ANSI Z87+ high mass velocity and impact requirements as well as ANSI Z136.1 and all international laser safety standards. A storage case and hang cord are included with every pair of Glendale XC safety eyewear, and all Glendale frames are backed by a lifetime guarantee.

GPT Glendale, Inc.
800.500.4739
www.glendalelaser.com

Dermacare Laser & Skin Care Clinics announced that it has joined the Laser Institute of America (LIA), the professional society dedicated to fostering lasers, laser applications, and laser safety worldwide to enhance industry safety.

“Our membership with the LIA will enable us to promote the safe use of lasers, which is perfectly aligned with our core principles of safety, efficacy, and service. Dermacare has long promoted strict regulation of laser procedures in the medspa industry,” explains Carl Mudd, Dermacare Founder and CEO. “This membership will also allow our physicians to take advantage of the additional training and networking opportunities, plus laser safety materials the LIA regularly produces.”

LIA, based in Orlando, Fla., comprises laser researchers, manufacturers, integrators, and end-users working together to increase the use and safe application of laser technologies. LIA individual and corporate members receive significant discounts on all LIA materials, training courses, and conferences.

Dermacare Laser & Skin Care Clinics
877.700.0788
www.dermacareusa.com

Beautiful Forever, a leading provider of medical business spa consulting services, is energized by the growing national trend to bring medspa services under the hospital umbrella. The trend to bring medspas to hospitals is rapidly gaining momentum nationwide, and the new revenue stream makes this trend a winner on hospitals’ ROI scorecard.

Heralding this trend, CEO Cheryl Whitman presented “Executing a Successful Hospital Retail Model of Business” at the recent Healthcare Retail ’06 which underscored the groundswell interest coast-to-coast from hospital executives eager to embrace this new trend as a major revenue producing business unit.

Hospitals nationwide are on a fact-finding and action-oriented mission to enhance business revenue by bringing ”in-house” their own medspa retail services, representing a growing business challenge to the free-standing medspas which have popped up during the last decade.

Says Whitman, “I do not believe the medical spa industry is heading into supermarkets and drugstores—instead the trend is moving towards the hospital retail business. Medical spas are growing. Hospitals want to be on the edge of new technology and are for the first time acknowledging the need to embark marketing and website programs to grow their retail businesses. And the reason for this is the widely accepted notion that wellness is key to staying youthful as well as healthful; and, therefore, there is no better place to get both than at your community hospital – a place you trust and know.”

Beautiful Forever
877.772.6334
www.medicalspaconsultant.com

Reliant Technologies, Inc., the pioneer of the breakthrough Fraxel® Laser, announced that Anja Krammer has joined the company as Vice President of Marketing. In her new role, Krammer will spearhead Reliant’s multi-faceted marketing initiatives in the company’s rapidly expanding physician and consumer market segments. Krammer will also be responsible for driving Reliant’s communications strategies with target audiences, ensuring the integration of all Reliant products into a cohesive brand marketing plan to support the revenue and growth objectives of the organization.

“The addition of Anja Krammer, a seasoned marketing veteran, is a testament to Reliant’s dynamic growth in the highly competitive laser medicine industry,” said Len DeBenedictis, President and Chief Executive Officer of Reliant Technologies. “We are fortunate to attract someone of Anja’s caliber to lead our marketing efforts. Her breadth of experience in business-to-business and direct-to-consumer marketing will serve all of our stakeholders well – from the physicians who embrace our products for their unmatched technological innovation to consumers who demand the best possible results for their aesthetic and medical conditions.”

“With the Fraxel laser’s recent U.S. Food and Drug Administration (FDA) clearances for acne scars and surgical scars, plus its already impressive roster of clearances for skin resurfacing, melasma and other conditions, there couldn’t be a better time to join a company that has such tremendous growth potential as Reliant,” said Krammer. “I’m excited to work with this world-class team of professionals in further expanding the Fraxel laser’s presence in the market.”

Reliant Technologies, Inc.
888.437.2935
www.reliant-tech.com

Radiancy, Inc., the global leader in light-based skin therapies, announced the appointment of Dr. Dolev Rafaeli as the new President and CEO. Dr.Rafaeli holds a Ph.D from Century University in New Mexico and a Masters degree from the Technion in Haifa, Israel. He formerly served as president of USR group and general manager of Orbotech (NASDAQ:ORBK) in China and Hong-Kong, along with senior positions in Motorola (NASDAQ:MOT).

“We are delighted to have Dr. Rafaeli as new CEO,” said Dr. Yoav Ben Dror, chairman of the board of Radiancy . “He is a major player in our market,” he explained. “With his deep knowledge and considerable experience we are certain he will make a significant contribution to the future of the company.”

Radiancy also announced the appointment of Eli Weissman as new Vice President of Operations. Mr. Weissman joins the organization with a solid background in operations management. He brings with him over 17 years of experience in Engineering, QA, product management, management of contract manufacturers, and other operations functions, working for such leading companies as Scitex (today Kodak, NASDAQ: EK), Elscint (today Philips Medical NYSE: PHG), GE Medical, (NYSE: GE), 3COM (NASDAQ: COMS), Alvarion (NASDAQ: ALVR) and Corrigent.

“We are very pleased to have Mr. Weissman on board,” said Dr. Dolev Rafaeli, President and CEO of Radiancy Inc. “Whenever there is a change in a key management position there are bound to be challenges as well as opportunities, Mr. Weissman has the experience and necessary skills to meet those challenges and we are certain that he will be a great asset to the organization.”

Radiancy Inc.
888.661.2220
www.radiancy.com

Palomar Medical Technologies Inc (Nasdaq: PMTI) announced that the U.S. District Court for the District of Massachusetts moved the start of the trial from May 30, 2006, to June 19, 2006, due to scheduling conflicts at the Court. In this lawsuit, Palomar has accused Cutera’s CoolGlide Laser Systems, including the CoolGlide CV, Excel, Vantage and Xeo, of infringing U.S. Patent No. 5,735,844. Palomar has an exclusive license to this patent from the General Hospital Corporation in Boston, Massachusetts.

Palomar is a leading researcher and developer of light-based systems for cosmetic treatments. Palomar pioneered the optical hair removal field when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology.

There are now millions of light-based cosmetic procedures performed around the world every year in physician offices, clinics, spas, and salons. Palomar is testing many new and exciting applications to further advance the hair removal market and other cosmetic applications. Palomar is uniquely focused on developing proprietary light-based technology for introduction to the mass markets.

Palomar Medical Technologies, Inc.
800.725.6627
www.palomarmedical.com

Cynosure, Inc. (NASDAQ: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, announced that it has received pre-market approval from the Korea Food and Drug Administration (KFDA) for its Cynergy vascular laser system with MultiPlex(TM) technology.

“We are excited about the opportunity to sell our leading-edge system in the emerging South Korean market,” said Cynosure Chief Executive Officer Michael R. Davin. “The Cynergy workstation with MultiPlex technology represents our second major product introduction in Korea this year.

“The Cynergy workstation with MultiPlex technology marks an innovative development in the treatment of dermatological vascular conditions through the use of laser-based technology,” Davin said. “This system is the culmination of significant research and development efforts internally and collaboratively with physicians at the forefront of their specialties.”

The Cynergy workstation with MultiPlex technology is the first system to enable the rapid sequential emission of two wavelengths from the same fiber optic — a pulse-dye laser and an Nd:YAG laser — with a short time delay between the two pulses. The time delay increases safety and efficacy of laser treatment.

In clinical studies, treatments using the Cynergy workstation with MultiPlex technology have shown an increased depth of penetration of energy and improved effectiveness in treating portwine stains, and improved outcomes for facial and leg telangiectasia when compared to treatments using a pulse-dye laser or an Nd:YAG laser individually. Previously, the limited efficacy of either a pulse-dye laser or an Nd:YAG laser in the treatment of portwine stains, hemangiomas and spider veins made those conditions resistant to treatment. Cynosure’s MultiPlex technology, however, allows for customized, patient-specific treatments using these two lasers together, which improves efficacy, decreases treatment lengths and shortens patient downtime.

Cynosure, Inc.
800.886.2966
www.cynosurelaser.com